• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

里斯黑变病的恶性转化:一例结膜黑色素瘤及相关治疗方式

Malignant Transformation of Reese's Melanosis: A Case of Conjunctival Melanoma and Related Therapeutic Modalities.

作者信息

Kharmach Ikram, Rezzoug Fatima, Moukhlissi Mohamed, Al Jarroudi Ouissam, Brahmi Sami Aziz, Afqir Said

机构信息

Medical Oncology, Mohammed VI University Hospital, Oujda, MAR.

Medical Oncology, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.

出版信息

Cureus. 2024 Jun 13;16(6):e62331. doi: 10.7759/cureus.62331. eCollection 2024 Jun.

DOI:10.7759/cureus.62331
PMID:39006575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11246170/
Abstract

Conjunctival melanoma is a rare but aggressive condition that can arise from healthy conjunctiva, pre-existing nevi, or precancerous conditions like Reese's melanosis. This acquired primary conjunctival melanosis can significantly impact an individual's quality of life due to its potential for recurrence and metastasis. Effective treatment typically requires a multidisciplinary approach to optimize outcomes. We present the case of a 56-year-old patient with recurrent Reese melanoma who underwent multiple surgeries. During the last intervention, a malignant transformation into melanoma was discovered. Due to the absence of brachytherapy facilities, the patient received local treatment with mitomycin C eye drops. Despite this limitation, the patient showed no signs of recurrence one year post-treatment. Given the high risk of local recurrence after surgery alone, additional radiotherapy is recommended and should be systematically discussed. Regular monitoring and timely intervention are essential to prevent disease progression. Notably, the frequent BRAF (B-Raf proto-oncogene, serine/threonine kinase) mutation in conjunctival melanoma opens possibilities for targeted therapies, such as BRAF inhibitors, offering promising options for management alongside traditional surgical approaches.

摘要

结膜黑色素瘤是一种罕见但侵袭性很强的疾病,可起源于健康的结膜、既往存在的痣或如里斯黑色素沉着症等癌前病变。这种后天性原发性结膜黑色素沉着症因其复发和转移的可能性,会对个人生活质量产生重大影响。有效的治疗通常需要多学科方法来优化治疗效果。我们报告一例56岁复发性里斯黑色素瘤患者,该患者接受了多次手术。在最后一次干预中,发现发生了恶性转化为黑色素瘤。由于缺乏近距离放射治疗设备,该患者接受了丝裂霉素C滴眼液局部治疗。尽管有此限制,但患者在治疗后一年未出现复发迹象。鉴于单纯手术后局部复发风险高,建议进行额外放疗,且应进行系统讨论。定期监测和及时干预对于预防疾病进展至关重要。值得注意的是,结膜黑色素瘤中频繁出现的BRAF(B-Raf原癌基因,丝氨酸/苏氨酸激酶)突变为靶向治疗开辟了可能性,如BRAF抑制剂,为与传统手术方法一起的治疗管理提供了有前景的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a451/11246170/0e39d25e9735/cureus-0016-00000062331-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a451/11246170/f9d04b3b1eb2/cureus-0016-00000062331-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a451/11246170/0e39d25e9735/cureus-0016-00000062331-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a451/11246170/f9d04b3b1eb2/cureus-0016-00000062331-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a451/11246170/0e39d25e9735/cureus-0016-00000062331-i02.jpg

相似文献

1
Malignant Transformation of Reese's Melanosis: A Case of Conjunctival Melanoma and Related Therapeutic Modalities.里斯黑变病的恶性转化:一例结膜黑色素瘤及相关治疗方式
Cureus. 2024 Jun 13;16(6):e62331. doi: 10.7759/cureus.62331. eCollection 2024 Jun.
2
[Reese's conjunctival melanosis. Two anatomicoclinical observations with ultrastructural study in one case].[里斯结膜黑变病。1例超微结构研究的两个解剖临床观察]
J Fr Ophtalmol. 1982;5(12):805-11.
3
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.局部丝裂霉素化疗治疗结膜恶性黑色素瘤和原发性获得性黑色素沉着伴异型性:组织病理学观察的临床经验
Arch Ophthalmol. 2000 Jul;118(7):885-91.
4
Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.结膜原发性获得性黑变病:311只眼进展为黑色素瘤的风险。2006年洛伦兹·E·齐默尔曼讲座
Ophthalmology. 2008 Mar;115(3):511-519.e2. doi: 10.1016/j.ophtha.2007.07.003. Epub 2007 Sep 20.
5
[Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].[丝裂霉素C治疗结膜黑色素瘤和原发性获得性黑色素沉着症]
Klin Monbl Augenheilkd. 1998 Jun;212(6):465-8. doi: 10.1055/s-2008-1034931.
6
[Conjunctival primary acquired melanosis].[结膜原发性获得性黑素沉着症]
Tidsskr Nor Laegeforen. 2005 Sep 22;125(18):2480-2.
7
[Malignant melanoma of the conjunctiva].[结膜恶性黑色素瘤]
Klin Monbl Augenheilkd. 2008 Jul;225(7):663-6. doi: 10.1055/s-2008-1027430.
8
Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.丹麦的结膜恶性黑色素瘤:流行病学、治疗与预后,特别强调肿瘤发生和基因概况
Acta Ophthalmol. 2016 May;94 Thesis 1:1-27. doi: 10.1111/aos.13100.
9
[Conjunctival melanoma at corneoscleral limbus on primary acquired melanosis. A case report].[原发性获得性黑色素沉着症合并角膜缘结膜黑色素瘤。病例报告]
J Fr Ophtalmol. 2007 Oct;30(8):e22. doi: 10.1016/s0181-5512(07)92620-0.
10
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.局部用丝裂霉素化疗治疗结膜恶性黑色素瘤和伴异型性的原发性后天性黑素沉着病:12年经验
Graefes Arch Clin Exp Ophthalmol. 2005 Nov;243(11):1108-14. doi: 10.1007/s00417-004-1080-y. Epub 2005 Jun 7.

本文引用的文献

1
Current Management of Conjunctival Melanoma Part 2: Treatment and Future Directions.当前结膜黑色素瘤的处理方法 第 2 部分:治疗与未来方向。
Turk J Ophthalmol. 2020 Dec 29;50(6):362-370. doi: 10.4274/tjo.galenos.2020.22567.
2
[Management of uveal melanomas, guidelines for oncologists].[葡萄膜黑色素瘤的管理,肿瘤学家指南]
Bull Cancer. 2018 Oct;105(10):967-980. doi: 10.1016/j.bulcan.2018.07.011. Epub 2018 Sep 11.
3
[Pleuropulmonary metastasis revealing a malignant melanoma of the conjunctiva in a young subject].[胸膜肺转移揭示一名年轻患者结膜恶性黑色素瘤]
Pan Afr Med J. 2016 Mar 15;23:98. doi: 10.11604/pamj.2016.23.98.7246. eCollection 2016.
4
Conjunctival melanoma: a review of conceptual and treatment advances.结膜黑色素瘤:概念与治疗进展综述
Clin Ophthalmol. 2013;6:521-31. doi: 10.2147/OPTH.S38415. Epub 2013 Mar 13.
5
Conjunctival melanoma and melanocytic intra-epithelial neoplasia.结膜黑色素瘤和黑色素细胞上皮内肿瘤。
Eye (Lond). 2013 Feb;27(2):142-52. doi: 10.1038/eye.2012.254. Epub 2012 Dec 7.
6
Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes.多重连接依赖性探针扩增检测结膜黑色素瘤发现常见的 BRAF V600E 基因突变和基因拷贝数变化。
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5598-604. doi: 10.1167/iovs.10-6934.
7
Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases.结膜黑色素瘤:382 例连续病例中基于肿瘤起源的结果。
Ophthalmology. 2011 Feb;118(2):389-95.e1-2. doi: 10.1016/j.ophtha.2010.06.021. Epub 2010 Aug 17.
8
Primary acquired melanosis of the conjunctiva: experience with 311 eyes.结膜原发性获得性黑变病:311只眼的经验
Trans Am Ophthalmol Soc. 2007;105:61-71; discussion 71-2.
9
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.局部用丝裂霉素化疗治疗结膜恶性黑色素瘤和伴异型性的原发性后天性黑素沉着病:12年经验
Graefes Arch Clin Exp Ophthalmol. 2005 Nov;243(11):1108-14. doi: 10.1007/s00417-004-1080-y. Epub 2005 Jun 7.
10
[Nodular melanoma on primary acquired conjunctival melanosis].原发性获得性结膜黑变病中的结节性黑色素瘤
J Fr Ophtalmol. 2005 Mar;28(3):331-5. doi: 10.1016/s0181-5512(05)81063-0.